Xortx Therapeutics Inc (XRTX)

$2.43 -0.03 (-1.22%)
Market Cap 3.43M
Revenue (ttm) 0.00
Net Income (ttm) -2.66M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 58,000
Avg Vol 1,543,665
Day's Range N/A - N/A
Shares Out 1.39M
Stochastic %K 25%
Beta 0.80
Analysts Strong Buy
Price Target $70.00

Company Profile

XORTX Therapeutics Inc., a late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat hyperuricemia related diseases in Canada. It develops XRx-026, which is in Phase III for the treatment of gout; XRx-008, which is in Phase II for the treatment of autosomal dominant polycystic kidney disease; XRx-101, which is in Phase II for the treatment of acute kidney injury associated with respiratory virus infection, including sepsis and coronavirus;...

Industry: Biotechnology
Sector: Healthcare
Phone: 403-455-7727
Address:
3710 - 33rd Street NW, Calgary, Canada
honestrick
honestrick May. 12 at 5:10 PM
$XRTX Let er RIP ....
0 · Reply
LookaLike
LookaLike May. 6 at 6:43 PM
$XRTX waiting for news
0 · Reply
SuperGreenToday
SuperGreenToday May. 5 at 6:31 PM
$XRTX
0 · Reply
honestrick
honestrick May. 4 at 2:17 PM
$BB All the heavy lifting has been done on these stocks $NXE $BLDP $XRTX $SEGG Over the past few years ... Its time to reap the benefits .
0 · Reply
LookaLike
LookaLike Apr. 30 at 6:40 PM
$XRTX hopefully next $DRUG
0 · Reply
LookaLike
LookaLike Apr. 24 at 4:39 PM
$XRTX yes picking up
0 · Reply
honestrick
honestrick Apr. 24 at 2:38 PM
$XRTX They may need $$$$ but with the pipe line they have and the 3 new directors who ALL have connections to investors $$$ should hold the price .It will bounce around but should start to climb . $DRUG
0 · Reply
honestrick
honestrick Apr. 24 at 2:28 PM
$XRTX
0 · Reply
LookaLike
LookaLike Apr. 23 at 6:27 PM
$XRTX the presplit price is 0,54, this is still very low. This should trade at least at 10 Million marketcap with the acquisition they finalized. This would translate into 7 $ per share considering 1.5 million shares outstanding
0 · Reply
LookaLike
LookaLike Apr. 22 at 7:03 PM
$XRTX from red to green, nice performance
0 · Reply
Latest News on XRTX
XORTX Regains Nasdaq Compliance, Stock Up

2026-04-21T14:45:55.000Z - 21 days ago

XORTX Regains Nasdaq Compliance, Stock Up

XRTX Achieves Nasdaq Compliance Following Share Price Recovery

2026-04-21T14:32:51.000Z - 21 days ago

XRTX Achieves Nasdaq Compliance Following Share Price Recovery

Xortx Therapeutics meets Nasdaq continued listing requirements

2026-04-21T12:45:47.000Z - 22 days ago

Xortx Therapeutics meets Nasdaq continued listing requirements

XORTX Closes Acquisition Of Kidney Anti-fibrotic Asset From Vectus; Stock Down

2026-04-14T06:56:22.000Z - 4 weeks ago

XORTX Closes Acquisition Of Kidney Anti-fibrotic Asset From Vectus; Stock Down

Xortx Therapeutics to effect 5-for-1 share consolidation on April 6

2026-04-01T17:05:46.000Z - 5 weeks ago

Xortx Therapeutics to effect 5-for-1 share consolidation on April 6

XORTX Confirms Effective Date of Share Consolidation

Wed, 01 Apr 2026 13:00:00 -0400 - 5 weeks ago

XORTX Confirms Effective Date of Share Consolidation

XORTX Announces Results of Annual and Special Meeting of Shareholders

Thu, 26 Mar 2026 18:00:00 -0400 - 6 weeks ago

XORTX Announces Results of Annual and Special Meeting of Shareholders

XORTX Announces Change of Effective Date of Share Consolidation

Thu, 26 Mar 2026 16:32:00 -0400 - 6 weeks ago

XORTX Announces Change of Effective Date of Share Consolidation

XORTX Announces Share Consolidation

Wed, 25 Mar 2026 18:15:00 -0400 - 6 weeks ago

XORTX Announces Share Consolidation

Xortx Therapeutics announces three new director nominees

2026-03-18T11:26:41.000Z - 2 months ago

Xortx Therapeutics announces three new director nominees

Xortx reports proxy firms recommend shareholders vote ‘FOR’ share consolidation

2026-03-13T11:11:51.000Z - 2 months ago

Xortx reports proxy firms recommend shareholders vote ‘FOR’ share consolidation

XORTX Reports that Independent Proxy Advisory Firms Recommend XORTX Shareholders Vote “For” the Share Consolidation

Fri, 13 Mar 2026 07:00:00 -0400 - 2 months ago

XORTX Reports that Independent Proxy Advisory Firms Recommend XORTX Shareholders Vote “For” the Share Consolidation

XORTX Therapeutics (XRTX) Announces Key Shareholder Meeting Agenda

2026-03-05T12:33:09.000Z - 2 months ago

XORTX Therapeutics (XRTX) Announces Key Shareholder Meeting Agenda

Xortx Therapeutics announces filing of meeting documents

2026-03-05T12:18:22.000Z - 2 months ago

Xortx Therapeutics announces filing of meeting documents

Why Align Technology Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket

2026-02-05T09:34:03.000Z - 3 months ago

Why Align Technology Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket

XORTX Extends Closing Of Renal Anti-Fibrotic Therapeutic Program Acquisition; Stock Soars

2026-02-05T07:10:06.000Z - 3 months ago

XORTX Extends Closing Of Renal Anti-Fibrotic Therapeutic Program Acquisition; Stock Soars

Xortx Therapeutics prices 1.75M shares at 63c in registered direct offering

2025-10-21T12:20:49.000Z - 7 months ago

Xortx Therapeutics prices 1.75M shares at 63c in registered direct offering

XORTX Announces Pricing of US$1.1 Million Registered Direct Offering

Tue, 21 Oct 2025 08:00:00 -0400 - 7 months ago

XORTX Announces Pricing of US$1.1 Million Registered Direct Offering

XORTX Therapeutics (XRTX) Secures Nasdaq Extension to Meet Bid Price Rule

2025-10-21T06:55:29.000Z - 7 months ago

XORTX Therapeutics (XRTX) Secures Nasdaq Extension to Meet Bid Price Rule

XORTX Issues Correction Notice and XORTX Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Deficiency

Mon, 20 Oct 2025 20:34:00 -0400 - 7 months ago

XORTX Issues Correction Notice and XORTX Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Deficiency

XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

Mon, 20 Oct 2025 18:45:00 -0400 - 7 months ago

XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

Why Is XORTX Therapeutics Stock (XRTX) Up 20% Today?

2025-10-17T13:42:59.000Z - 7 months ago

Why Is XORTX Therapeutics Stock (XRTX) Up 20% Today?

XORTX (XRTX) Acquires Renal Therapeutic Program from Vectus

2025-10-17T12:35:39.000Z - 7 months ago

XORTX (XRTX) Acquires Renal Therapeutic Program from Vectus

Xortx to acquire Renal Anti-Fibrotic Therapeutic Program from Vectus for $3M

2025-10-17T11:05:16.000Z - 7 months ago

Xortx to acquire Renal Anti-Fibrotic Therapeutic Program from Vectus for $3M

XORTX Announces Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems

Fri, 17 Oct 2025 07:00:00 -0400 - 7 months ago

XORTX Announces Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems

Xortx Therapeutics files to sell 4.76M common shares

2025-09-25T20:25:29.000Z - 8 months ago

Xortx Therapeutics files to sell 4.76M common shares

XORTX Therapeutics goes ‘toe to toe’ with gout by accelerating its lead drug program targeting this complex disease

2025-09-09T13:01:00.000Z - 8 months ago

XORTX Therapeutics goes ‘toe to toe’ with gout by accelerating its lead drug program targeting this complex disease

Xortx Therapeutics initiates IND preparation for XORLO in gout program

2025-09-03T11:11:43.000Z - 9 months ago

Xortx Therapeutics initiates IND preparation for XORLO in gout program

XORTX Initiates IND Preparation for XORLO™ in Gout Program

Wed, 03 Sep 2025 07:00:00 -0400 - 9 months ago

XORTX Initiates IND Preparation for XORLO™ in Gout Program

XORTX Completes USD $114,500 Private Placement

Fri, 08 Aug 2025 19:54:00 -0400 - 9 months ago

XORTX Completes USD $114,500 Private Placement

Xortx Therapeutics announces planned goals for 2026

2025-08-07T12:02:26.000Z - 9 months ago

Xortx Therapeutics announces planned goals for 2026

Xortx Therapeutics prices 156,849 units at 73c in private placement

2025-07-31T11:20:31.000Z - 10 months ago

Xortx Therapeutics prices 156,849 units at 73c in private placement

XORTX Completes Non-Brokered Private Placement of Units

Tue, 22 Jul 2025 19:59:00 -0400 - 10 months ago

XORTX Completes Non-Brokered Private Placement of Units

XORTX Announces USD $925,000 Private Placement

Thu, 26 Jun 2025 07:00:00 -0400 - 11 months ago

XORTX Announces USD $925,000 Private Placement

Xortx Therapeutics prices 3.41M units at 88c in private placement

2025-05-19T11:15:25.000Z - 1 year ago

Xortx Therapeutics prices 3.41M units at 88c in private placement

XORTX Announces USD $3 Million Offering

Mon, 19 May 2025 07:00:00 -0400 - 1 year ago

XORTX Announces USD $3 Million Offering

Xortx Therapeutics provides update on FDA Type B meeting request

2025-04-30T11:14:55.000Z - 1 year ago

Xortx Therapeutics provides update on FDA Type B meeting request

Xortx Therapeutics announces grant of European patent

2025-04-28T11:11:02.000Z - 1 year ago

Xortx Therapeutics announces grant of European patent

XORTX Therapeutics (XRTX) Faces Nasdaq Compliance Challenge

2025-04-18T07:55:25.000Z - 1 year ago

XORTX Therapeutics (XRTX) Faces Nasdaq Compliance Challenge

Xortx Therapeutics discloses Nasdaq notification regarding minimum bid price

2025-04-18T00:00:24.000Z - 1 year ago

Xortx Therapeutics discloses Nasdaq notification regarding minimum bid price

XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

Thu, 17 Apr 2025 19:45:00 -0400 - 1 year ago

XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

Xortx Therapeutics to provide Type B meeting package to FDA during next week

2025-03-19T11:15:53.000Z - 1 year ago

Xortx Therapeutics to provide Type B meeting package to FDA during next week

Xortx Therapeutics commences gout program NDA discussions with FDA

2025-02-24T12:31:11.000Z - 1 year ago

Xortx Therapeutics commences gout program NDA discussions with FDA

ARMISTICE CAPITAL, LLC Acquires Shares in XORTX Therapeutics Inc

2025-02-15T11:02:46.000Z - 1 year ago

ARMISTICE CAPITAL, LLC Acquires Shares in XORTX Therapeutics Inc

XORTX Announces Change of Auditor

Fri, 17 Jan 2025 17:00:00 -0500 - 1 year ago

XORTX Announces Change of Auditor

IRW-News: XORTX Therapeutics Inc.: XORTX kündigt Präsentation auf dem Rare and Genetic Disease Summit an

2024-12-13T07:01:58.000Z - 1 year ago

IRW-News: XORTX Therapeutics Inc.: XORTX kündigt Präsentation auf dem Rare and Genetic Disease Summit an

XORTX Announces Presentation at the Rare and Genetic Disease Summit

Thu, 12 Dec 2024 09:17:00 -0500 - 1 year ago

XORTX Announces Presentation at the Rare and Genetic Disease Summit

XORTX Announces Closing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement

Fri, 18 Oct 2024 16:00:00 -0400 - 1 year ago

XORTX Announces Closing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement

XORTX Initiates Precision Medicine Program

Wed, 09 Oct 2024 05:00:00 -0400 - 1 year ago

XORTX Initiates Precision Medicine Program

XORTX Announces Results of Annual and Special Meeting of Shareholders

Fri, 13 Sep 2024 07:00:00 -0400 - 1 year ago

XORTX Announces Results of Annual and Special Meeting of Shareholders

XORTX Announces Re-filing of YE 2023 and Q2 2024 MD&A

Sep 12, 2024, 5:30 PM EDT - 1 year ago

XORTX Announces Re-filing of YE 2023 and Q2 2024 MD&A

XORTX Reminds Shareholders of Voting Deadline for Upcoming Annual and Special Meeting of Shareholders

Sep 6, 2024, 5:30 PM EDT - 1 year ago

XORTX Reminds Shareholders of Voting Deadline for Upcoming Annual and Special Meeting of Shareholders

Independent Proxy Advisory Firm ISS Recommends XORTX Shareholders Vote FOR ALL Proposed Items at the Upcoming Annual and Special Meeting of Shareholders

Sep 3, 2024, 12:30 PM EDT - 1 year ago

Independent Proxy Advisory Firm ISS Recommends XORTX Shareholders Vote FOR ALL Proposed Items at the Upcoming Annual and Special Meeting of Shareholders

XORTX Announces Filing and Mailing of the Meeting Documents in Connection with the Annual and Special Meeting of Shareholders

Aug 23, 2024, 7:00 AM EDT - 1 year ago

XORTX Announces Filing and Mailing of the Meeting Documents in Connection with the Annual and Special Meeting of Shareholders

XORTX Announces Presentation at American Society of Nephrology – Kidney Week 2024

Aug 20, 2024, 7:00 AM EDT - 1 year ago

XORTX Announces Presentation at American Society of Nephrology – Kidney Week 2024

XORTX Reprices Balance of Warrants Issued in Connection with October 2021 US IPO

May 17, 2024, 7:00 AM EDT - 2 years ago

XORTX Reprices Balance of Warrants Issued in Connection with October 2021 US IPO

XORTX Reprices Warrants Issued in Connection with Previous Private Placements

Apr 30, 2024, 1:54 PM EDT - 2 years ago

XORTX Reprices Warrants Issued in Connection with Previous Private Placements

XORTX Announces Publication of Key Research in ADPKD

Apr 22, 2024, 7:00 AM EDT - 2 years ago

XORTX Announces Publication of Key Research in ADPKD

XORTX Welcomes New Member to the Board of Directors

Apr 8, 2024, 7:30 AM EDT - 2 years ago

XORTX Welcomes New Member to the Board of Directors

XORTX Announces New Clinical Advisory Board Member

Mar 27, 2024, 5:00 AM EDT - 2 years ago

XORTX Announces New Clinical Advisory Board Member

XORTX Highlights Achievements of 2023 and Preparation for Registration Clinical Trial

Mar 19, 2024, 5:00 AM EDT - 2 years ago

XORTX Highlights Achievements of 2023 and Preparation for Registration Clinical Trial

XORTX Finalizes $2.7 Million Prospectus Supplement and Concurrent Private Placement for the Offering of Units

Mar 4, 2024, 7:00 AM EST - 2 years ago

XORTX Finalizes $2.7 Million Prospectus Supplement and Concurrent Private Placement for the Offering of Units

XORTX Files an Amended and Restated Prospectus Supplement for the Offering of Units

Feb 1, 2024, 8:46 PM EST - 2 years ago

XORTX Files an Amended and Restated Prospectus Supplement for the Offering of Units

XORTX Announces $2 Million Public Offering

Jan 15, 2024, 7:00 AM EST - 2 years ago

XORTX Announces $2 Million Public Offering

XORTX Submits a New Patent for the Treatment of Chronic Kidney Disease

Jan 3, 2024, 7:00 AM EST - 2 years ago

XORTX Submits a New Patent for the Treatment of Chronic Kidney Disease

XORTX Announces US ATM Offering

Nov 30, 2023, 7:30 AM EST - 2 years ago

XORTX Announces US ATM Offering

XORTX Meets Nasdaq Continued Listing Requirements

Nov 29, 2023, 7:00 AM EST - 2 years ago

XORTX Meets Nasdaq Continued Listing Requirements

XORTX Clarifies Timing for Share Consolidation

Nov 10, 2023, 7:00 AM EST - 2 years ago

XORTX Clarifies Timing for Share Consolidation

XORTX Announces Results of Special Meeting of Shareholders

Oct 27, 2023, 5:30 PM EDT - 2 years ago

XORTX Announces Results of Special Meeting of Shareholders

XORTX Announces Date for Rescheduled Special Meeting of Shareholders

Oct 25, 2023, 5:00 PM EDT - 2 years ago

XORTX Announces Date for Rescheduled Special Meeting of Shareholders

XORTX Announces Rescheduling of Special Meeting of Shareholders

Oct 25, 2023, 7:00 AM EDT - 2 years ago

XORTX Announces Rescheduling of Special Meeting of Shareholders

XORTX Reports that Independent Proxy Firm, ISS, Recommends Shareholders Vote for the Share Consolidation Resolution

Oct 12, 2023, 7:00 AM EDT - 2 years ago

XORTX Reports that Independent Proxy Firm, ISS, Recommends Shareholders Vote for the Share Consolidation Resolution

XORTX Calls Special Meeting of Shareholders

Oct 4, 2023, 7:00 AM EDT - 2 years ago

XORTX Calls Special Meeting of Shareholders

XORTX Submits Orphan Drug Designation Application to the European Medicines Agency (EMA) to Treat Progressive Kidney Disease

Aug 29, 2023, 7:00 AM EDT - 2 years ago

XORTX Submits Orphan Drug Designation Application to the European Medicines Agency (EMA) to Treat Progressive Kidney Disease

XORTX Appoints Chief Financial Officer

Aug 4, 2023, 5:00 PM EDT - 3 years ago

XORTX Appoints Chief Financial Officer

XORTX Reminds Shareholders to Vote ahead of the Proxy Voting Deadline for the Company's Upcoming Annual and Special Meeting of Shareholders

Jun 23, 2023, 8:51 PM EDT - 3 years ago

XORTX Reminds Shareholders to Vote ahead of the Proxy Voting Deadline for the Company's Upcoming Annual and Special Meeting of Shareholders

XORTX Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Deficiency

May 24, 2023, 7:00 AM EDT - 3 years ago

XORTX Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Deficiency

XORTX Announces Receipt of FDA Orphan Drug Designation to Treat Autosomal Dominant Kidney Disease

Apr 21, 2023, 7:00 AM EDT - 3 years ago

XORTX Announces Receipt of FDA Orphan Drug Designation to Treat Autosomal Dominant Kidney Disease

XORTX Announces Submission of Orphan Drug Designation Request for XRx-008 Program to Treat Autosomal Dominant Kidney Disease

Feb 1, 2023, 7:00 AM EST - 3 years ago

XORTX Announces Submission of Orphan Drug Designation Request for XRx-008 Program to Treat Autosomal Dominant Kidney Disease

XORTX Announces Positive Topline Results from XRX-OXY-101 Clinical Trial

Jan 19, 2023, 7:00 AM EST - 3 years ago

XORTX Announces Positive Topline Results from XRX-OXY-101 Clinical Trial

honestrick
honestrick May. 12 at 5:10 PM
$XRTX Let er RIP ....
0 · Reply
LookaLike
LookaLike May. 6 at 6:43 PM
$XRTX waiting for news
0 · Reply
SuperGreenToday
SuperGreenToday May. 5 at 6:31 PM
$XRTX
0 · Reply
honestrick
honestrick May. 4 at 2:17 PM
$BB All the heavy lifting has been done on these stocks $NXE $BLDP $XRTX $SEGG Over the past few years ... Its time to reap the benefits .
0 · Reply
LookaLike
LookaLike Apr. 30 at 6:40 PM
$XRTX hopefully next $DRUG
0 · Reply
LookaLike
LookaLike Apr. 24 at 4:39 PM
$XRTX yes picking up
0 · Reply
honestrick
honestrick Apr. 24 at 2:38 PM
$XRTX They may need $$$$ but with the pipe line they have and the 3 new directors who ALL have connections to investors $$$ should hold the price .It will bounce around but should start to climb . $DRUG
0 · Reply
honestrick
honestrick Apr. 24 at 2:28 PM
$XRTX
0 · Reply
LookaLike
LookaLike Apr. 23 at 6:27 PM
$XRTX the presplit price is 0,54, this is still very low. This should trade at least at 10 Million marketcap with the acquisition they finalized. This would translate into 7 $ per share considering 1.5 million shares outstanding
0 · Reply
LookaLike
LookaLike Apr. 22 at 7:03 PM
$XRTX from red to green, nice performance
0 · Reply
TheBeautifulGopher
TheBeautifulGopher Apr. 22 at 1:01 PM
$XRTX hello XRTX board, you had a nice pop for compliance news. $HKIT did their reverse split the same time as you and we’re waiting for ours. Should be getting it tomorrow 😎
0 · Reply
Goldwave9
Goldwave9 Apr. 22 at 12:39 PM
$XRTX Another sleeper that's playing dead...for now
0 · Reply
Mr_Stochastic
Mr_Stochastic Apr. 22 at 11:17 AM
$XRTX $BATL $FFAI $SOXL
0 · Reply
DavidScott
DavidScott Apr. 22 at 4:22 AM
On watch tomorrow (momentum) // Part 1 🔥📈📚 $BYND $LOBO $FCHL $RPGL $XRTX
0 · Reply
DayTrade_4Life
DayTrade_4Life Apr. 22 at 12:21 AM
💵From the Watchlist and Alerts Today 21 April 26: 💪See image for Top Alerts this month. $SPRC: 5.33 to 8.42 (57%) $LOBO: .91 to 1.35 (48%) $RPGL: .65 to .92 (41%) $EDBL: 1.28 to 1.65 (28%) $XRTX: 2.94 to 3.73 (26%) TDIC: 1 to 1.20 (20%) VELO: 14 to 16.10 (13%)
0 · Reply
Longislandbull
Longislandbull Apr. 22 at 12:10 AM
We banked HARD today in so many different names! One of our co founders made $202K on the day! Come trade with us for a free week trial below 👇 https://trifectatrading.tiiny.site/ $NAIL $LOBO $LWLG $XRTX $IGV
0 · Reply
Oooox
Oooox Apr. 22 at 12:00 AM
$XRTX 🚀📍
0 · Reply
Mr_Stochastic
Mr_Stochastic Apr. 21 at 10:04 PM
$XRTX $BATL $FFAI $SOXL Testing out $BANL for an overnight hold. 💪🏼😎💰
0 · Reply
BreakoutBullz
BreakoutBullz Apr. 21 at 9:32 PM
🛎️🤑 Trade Recap 🤑🛎️ $LOBO ran 🔥💰🎯 +42% from .95 call! $XRTX ran 🔥💰🎯 +33% from 2.80 call! $EDBL 🔥💰🎯 +32% from 1.25 call! $FFAI ran 🔥💰🎯 +24% from .48 call! $TDIC 🔥💰🎯 +20% from .90 call!
0 · Reply
Mr_Stochastic
Mr_Stochastic Apr. 21 at 8:31 PM
$XRTX $BATL $FFAI $SOXL tomorrow we ride again! Until then....
0 · Reply
Mr_Stochastic
Mr_Stochastic Apr. 21 at 8:06 PM
$XRTX $BATL $FFAI $SOXL hope you banked with me today. Banger after banger!!! Follow. Subscribe. Bank. 💪🏼😎💰
1 · Reply
Reda1235
Reda1235 Apr. 21 at 7:30 PM
$XRTX
0 · Reply